These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29232954)

  • 1. Efficacy and Safety Profiles of Oral Atorvastatin-Loaded Nanoparticles: Effect of Size Modulation on Biodistribution.
    Ahmed IS; El Hosary R; Hassan MA; Haider M; Abd-Rabo MM
    Mol Pharm; 2018 Jan; 15(1):247-255. PubMed ID: 29232954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles.
    Ahmed IS; El-Hosary R; Shalaby S; Abd-Rabo MM; Elkhateeb DG; Nour S
    Int J Pharm; 2016 May; 504(1-2):70-9. PubMed ID: 27021467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-fat diet induced alteration in lipid enzymes and inflammation in cardiac and brain tissues: Assessment of the effects of Atorvastatin-loaded nanoparticles.
    Abd-Rabo MM; Wahman LF; El Hosary R; Ahmed IS
    J Biochem Mol Toxicol; 2020 May; 34(5):e22465. PubMed ID: 32048413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia.
    Meena AK; Ratnam DV; Chandraiah G; Ankola DD; Rao PR; Kumar MN
    Lipids; 2008 Mar; 43(3):231-41. PubMed ID: 18196308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Phospholipid Complex and Submicron Emulsion Techniques for Improving Oral Bioavailability and Therapeutic Efficacy of Water-Insoluble Drug.
    Qin L; Niu Y; Wang Y; Chen X
    Mol Pharm; 2018 Mar; 15(3):1238-1247. PubMed ID: 29412674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia.
    Mathur M; Devi Vemula K
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2048-2060. PubMed ID: 30073852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Gegenqinlian Decoction on Pharmacokinetics and Pharmacodynamics of Atorvastatin Calcium in Hyperlipidemic Rats.
    Cui M; Zhu F; Yin Y; Sui Y; Yan X; Chen T
    Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):117-126. PubMed ID: 34855161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration
    Li Z; Tao W; Zhang D; Wu C; Song B; Wang S; Wang T; Hu M; Liu X; Wang Y; Sun Y; Sun J
    Asian J Pharm Sci; 2017 May; 12(3):285-291. PubMed ID: 32104340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
    Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential.
    Sharma M; Mehta I
    Sci Rep; 2019 Nov; 9(1):16105. PubMed ID: 31695118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles.
    Shaker MA; Elbadawy HM; Al Thagfan SS; Shaker MA
    Int J Pharm; 2021 Jan; 592():120077. PubMed ID: 33246047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation.
    Omari-Siaw E; Zhu Y; Wang H; Peng W; Firempong CK; Wang YW; Cao X; Deng W; Yu J; Xu X
    Eur J Pharm Sci; 2016 Mar; 85():112-22. PubMed ID: 26851382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
    Li XP; Duan J; Zhao SP; Tan MY; Xu ZM; Zhang DQ
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2399-403. PubMed ID: 17156651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, and optimization of transdermal Atorvastatin Calcium-Loaded Ultra-flexible vesicles; ameliorates poloxamer 407-caused dyslipidemia.
    Akl MA; Ryad S; Ibrahim MF; Kassem AA
    Int J Pharm; 2023 May; 638():122917. PubMed ID: 37019321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin.
    Krauss RM; Pinto CA; Liu Y; Johnson-Levonas AO; Dansky HM
    J Clin Lipidol; 2015; 9(1):93-102. PubMed ID: 25670366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
    Shilpi D; Kushwah V; Agrawal AK; Jain S
    Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure.
    Saltissi D; Westhuyzen J; Morgan C; Healy H
    Clin Exp Nephrol; 2006 Sep; 10(3):201-9. PubMed ID: 17009078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
    Bagad M; Khan ZA
    Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of plasma cholesterol and triglyceride concentrations and eritoran (E5564) micelle size on its plasma pharmacokinetics and ex vivo activity following single intravenous bolus dose into healthy female rabbits.
    Wasan KM; Risovic V; Sivak O; Lee SD; Mason DX; Chiklis GR; McShane J; Lynn M; Wong N; Rossignol DP
    Pharm Res; 2008 Jan; 25(1):176-82. PubMed ID: 17849177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin calcium encapsulated eudragit nanoparticles with enhanced oral bioavailability, safety and efficacy profile.
    Kumar N; Chaurasia S; Patel RR; Khan G; Kumar V; Mishra B
    Pharm Dev Technol; 2017 Mar; 22(2):156-167. PubMed ID: 26555483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.